FindTrial
Sign In

A risk modeling study to predict vulnerability to error with inhaled drug devices in patients with chronic obstructive pulmonary disease

A risk modeling study to predict vulnerability to error with inhaled drug devices in patients with chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113276
Enrollment
Unknown
Registered
2025-11-26
Start date
2023-07-04
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Using inhalation devices correctly group:None
Using inhalation devices incorrectly group:None

Sponsors

The Third Affiliated Hosptial of ChongQing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Clinical diagnosis: Chronic Obstructive Pulmonary Disease; 2.Use of inhalation device for >= 30 days; 3.Voluntarily participate in the questionnaire survey and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Those with severe symptoms of heart, liver, kidney, blood, or nervous system diseases who are unable to cooperate with the investigators; 2.Pregnant women, women planning to become pregnant, or lactating women.

Design outcomes

Primary

MeasureTime frame
Whether the device is used correctly;—

Countries

China

Contacts

Public Contactfengting

The Third Affiliated Hosptial of ChongQing Medical University

304320002@qq.com+86 23 60353365

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026